A new rapid test for hepatitis C could help identify many more patients who could be cured of the deadly disease, but its use may be limited unless insurers’ reimbursement rises to cover its high cost ...
The FDA has greenlit its first point-of-care diagnostic test for hepatitis C, capable of using only a fingerstick blood sample, in a bid to quickly connect patients with antiviral drugs. “Despite the ...
BETHLEHEM, Pa., Feb. 22, 2011 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) announced today that its OraQuick ® HCV Rapid Antibody Test has now been approved by the U.S. Food and Drug ...
For patients living in areas with limited healthcare resources, WHO prequalification ensures access to the highest quality diagnostics Access to broader reliable diagnostic solutions helps healthcare ...
Please provide your email address to receive an email when new articles are posted on . Intelligent liver function testing successfully identified patients with hepatitis C who were previously ...
2. Zoratti M.J. Siddiqua A., Morassut R.E., Zeraatkar D., Chou R., Holten J., Xie F., Druyts E. Elsevier Clinical Medicine. 2020; 18, 100237. 3. Collins L.F., Chan A ...
Hepatitis C infection. Computer illustration showing liver and close-up view of hepatitis C viruses. Studies show that mortality, morbidity, and hepatic decompensation risks increase with coinfection ...
Please provide your email address to receive an email when new articles are posted on . Triple testing for HIV, HBV and HCV would identify an additional five HBV and three HCV cases for each HIV case.
Hepatitis C is the most common chronic bloodborne illness in the United States. In 2016, at least 2.4 million U.S. people were living with hepatitis C. Mothers with hepatitis C transmit the virus to 4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results